Disclaimer PubMed and NLM

2022 August 06
1.
G9a dictates neuronal vulnerability to inflammatory stress via transcriptional control of ferroptosis. Rothammer N, Woo MS, Bauer S, Binkle-Ladisch L, Di Liberto G, Egervari K, Wagner I, Haferkamp U, Pless O, Merkler D, Engler JB, Friese MA.
Sci Adv. 2022 Aug 5;8(31):eabm5500. doi: 10.1126/sciadv.abm5500. Epub 2022 Aug 5.
PMID: 35930635
2.
Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4. Meuth SG, Bayas A, Kallmann B, Linker R, Rieckmann P, Wattjes MP, Mäurer M, Kleinschnitz C.
Expert Opin Pharmacother. 2022 Aug 5:1-8. doi: 10.1080/14656566.2022.2106783. Online ahead of print.
PMID: 35930260
3.
Comparing virtual reality exergaming with conventional exercise in rehabilitation of people with multiple sclerosis: A systematic review. Moeinzadeh AM, Calder A, Petersen C, Hoermann S, Daneshfar A.
Neuropsychol Rehabil. 2022 Aug 5:1-27. doi: 10.1080/09602011.2022.2107021. Online ahead of print.
PMID: 35929897
4.
Evaluation of the blood neutrophil-to-lymphocyte ratio as a biomarker for meningoencephalitis of unknown etiology in dogs. Park J, Lee D, Yun T, Koo Y, Chae Y, Kim H, Yang MP, Kang BT.
J Vet Intern Med. 2022 Aug 5. doi: 10.1111/jvim.16512. Online ahead of print.
PMID: 35929724
5.
Tip-concentrated microneedle patch delivering everolimus for therapy of multiple sclerosis. Yang Y, Song W, Wang N, Ren Y, Liu H.
Biomater Adv. 2022 Apr;135:212729. doi: 10.1016/j.bioadv.2022.212729. Epub 2022 Apr 22.
PMID: 35929200
6.
Altered muscle oxidative phenotype impairs exercise tolerance but does not improve after exercise training in multiple sclerosis. Spaas J, Goulding RP, Keytsman C, Fonteyn L, van Horssen J, Jaspers RT, Eijnde BO, Wüst RCI.
J Cachexia Sarcopenia Muscle. 2022 Aug 4. doi: 10.1002/jcsm.13050. Online ahead of print.
PMID: 35929063
7.
Tuberous Sclerosis Complex With Multiple Organ Tumors: Case Report and Literature Review. Zhang X, Zhong X, Lin X, Li X, Tian H, Chang B, Wang Y, Tong J, Wang N, Li D, Jin X, Huang D, Wang Y, Cui H, Guan L, Li Y.
Front Oncol. 2022 Jul 19;12:916016. doi: 10.3389/fonc.2022.916016. eCollection 2022.
PMID: 35928867 Free PMC article. Review.
8.
Immunomodulatory effects of microbiota-derived metabolites at the crossroad of neurodegenerative diseases and viral infection: network-based bioinformatics insights. Onisiforou A, Spyrou GM.
Front Immunol. 2022 Jul 19;13:843128. doi: 10.3389/fimmu.2022.843128. eCollection 2022.
PMID: 35928817 Free PMC article.
9.
Exosomes with FOXP3 from gene-modified dendritic cells ameliorate the development of EAE by regulating the balance of Th/Treg. Jia Z, Liu J, Li B, Yi L, Wu Y, Xing J, Wang L, Wang J, Guo L.
Int J Med Sci. 2022 Jul 11;19(8):1265-1274. doi: 10.7150/ijms.72655. eCollection 2022.
PMID: 35928722 Free PMC article.
10.
Neurological Disease-Affected Patients, including Multiple Sclerosis, Are Poor Responders to BKPyV, a Human Polyomavirus. Bononi I, Mazzoni E, Pietrobon S, Iaquinta MR, Caselli A, Torreggiani E, Pugliatti M, Casetta I, Castellazzi M, Granieri E, Martini F, Tognon M.
J Immunol Res. 2022 Jul 26;2022:4864950. doi: 10.1155/2022/4864950. eCollection 2022.
PMID: 35928630 Free PMC article.
11.
Editorial: Multiple Sclerosis and Neuroimmunology-Case Report Collection, Volume I. Weissert R.
Front Neurol. 2022 Jul 13;13:976913. doi: 10.3389/fneur.2022.976913. eCollection 2022.
PMID: 35928128 Free PMC article. No abstract available.
12.
Use of electronic medical records to monitor the safe and effective prescribing of medicinal cannabis: is it feasible? Hallinan CM, Gunn JM, Bonomo YA.
Aust J Prim Health. 2022 Aug 5. doi: 10.1071/PY22054. Online ahead of print.
PMID: 35927928